chrisvoncsefalvay/vaers-outcomes huggingface dataset:
she got a little flushed; had a weird taste in her mouth; then a burning sensation on her tongue.; Caller stated it triggered her panic attacks.; anxiety really bad.; had acid reflux and stated she was afraid to go to bed; the shot made her nervous; This is a spontaneous report from a contactable consumer (patient). A 40-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown), via an unspecified route of administration, administered in left arm on 20Apr2021 as a single dose for COVID-19 immunisation. Medical history included autoimmune disorder. The patient has allergic to amoxicillin, penicillin, cefdinir, codeine, phenergan and contrast dye with iodine. Concomitant medications were not reported. On unknown date Caller stated she got the Pfizer covid 19 vaccine yesterday, 20Apr2021, patient experienced right after the shot she got a little flushed, anxious and had a weird taste in her mouth then a burning sensation on her tongue. Caller stated the nurse said it was not an anaphylactic reaction. Patient waited 20 to 25 minutes after the vaccine at the facility and stated it triggered her panic attacks, had anxiety really bad. She came home and worried all night and had acid reflux and stated she was afraid to go to bed last night because she did not know what was going to happen. Caller stated her PCP told her she had heard of others that have the burning tongue and she had the burning only slightly today. Caller reported no swelling and stated the shot made her nervous and she did get anxious and could be due to panic. Caller asked should she get the second dose and stated she was autoimmune. Caller stated she took contrast dye with iodine and it made her feel super drugged and she took guiafenesin with codeine and had to go to the ER because her throat and mouth were on fire. Caller had an appointment at 1:00 and did not have time to be transferred. The patient visited emergency room (ER) because her throat and mouth were on fire on unknown date. The patient received treatment for the events with contrast dye with iodine and guiafenesin with codeine. The outcome of the events was unknown.  No Follow-up attempts are needed. No further information is expected.
71 yo female developed diffuse myalgias then pain that localized to L UE around injection. Also with HA nausea & cellulitis of L UE.
reporter indicated that multiple (but not too many) pts who recvd a series of 3 doses or Recombivax did not respond p/3rd dose; switched to Engerix-B & now do not have this problem w/non-response anymore;
REDNESS, INFLAMMATION AND ITCHING AT SITE AND AROUND AREA OF ADMINISTRATION. PATIENT OBSERVED THIS REACTION AFTER 6 DAYS OF VACCINE ADMINISTRATION. PATIENT APPLIED BENADRYL CREAM TO SOOTHE THE AREA. PATIENT WILL CONSULT WITH HER PRIMARY CARE PHYSICIAN ON 02/18/2020
Patient queried for Adult vaccine questionnaire patient answered no to question #8 (Are you currently pregnant or plan on becoming pregnant?) Immunization given.
Mom states child does not act the same since injections. No rash, no fever, no objective finding. No swelling.
Shortly after vaccine administration patient became dizzy, sweaty, and started to see black dots with her vision.  On assessment pt was found to be hypotensive with systolic BPs typically in the 90s but BP got as low as 79/50.  Initial suspicion became a vagal event and patient was monitored by MD for approximately 30 minutes until symptoms resolved.  At approximately 1330 patient started to experience cramping with slight bleeding and was sent to labor and delivery for assessment.  Patient has an EDD of 06/29/22.
weakness, dizziness for about 2 minutes at that time BP 97/67 pt observed for additional 30 minutes bp at that time 112/70, left with family no LOC observed
Muscle pain, Arm numbness, Lymph nodes under armpits swollen and tender, malaise, dizziness, drowsiness
Patient received ZOSTAVAX and showed up 4 days later with red area around injection site.
At lunch time the patient indicated he had pain in his left arm. The patient's mother noted his arm was red. The patient was seen in the Public Health Office and was noted to have a 30mm non-tender, soft, warm to touch red area on the back of his left arm. On 09/17/2001 the patient's father advised everything is OK now.
Intermittent numbness and itching of the tongue. Resolves without intervention. Still ongoing intermittently for 3 weeks.
Patient claims that the injection hurt really bad and that she is still having pain to this day. Her mom feels that the injection site was to high on the arm.
Diarrhea, vomiting, cough 2 days after flu shot and fever 3 days after flu shot
Information has been received from a physician via a pharmacist and a health professional at a physician's office concerning a 77 year old male with diabetes, hypertension, hypercholesterolaemia and arteriosclerotic heart disease and a history of coronary artery bypass who on an unspecified date was vaccinated intramuscularly with Pneumovax 23 (lot # 654977/0888F).  Subsequently the patient developed cellulitis at the injection site.  Unspecified medical attention was sought.  At the time of this report, the outcome of the event was unknown.  Additional information has been requested.
Hypotonic and fever event enough for  hospital to do a full septic w/u and given Ceftriaxime x 2 days.
Patient complained of itching, redness. Took Benadryl and it improved. Still had symptoms for over a week, said it wasn't improving and still red and swollen and sore. Recommended seeing a physician incase area was infected. Haven't heard from patient to see if she did see someone.
Expired Vaccine administered to patient; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired Vaccine administered to patient) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939902) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired Vaccine administered to patient). On 03-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Expired Vaccine administered to patient) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It is reported that 1 Vial of Moderna COVID-19 vaccine was taken out of the refrigerator, punctured and kept at  room temperature (67.2F) beyond 12 hours. The vial was first punctured at 1:01 PM on 31-JUL-2021.  Patient received his second dose of Moderna COVID-19 Vaccine from a vial that was expired (21 hours and 20 minutes at 67.2 Fahrenheit steady temperature).  No concomitant medication was provided. No treatment medication was provided.   This case was linked to MOD-2021-273129, MOD-2021-273149, MOD-2021-273286, MOD-2021-273448, MOD-2021-273721 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-Aug-2021: Follow up document received and patient race, ethnicity and patient anatomical location of second dose is updated.
One week after 1st covid vaccine pt. c/o itching and rash on right lower jaw, worse at night, helped with OTC cortisone cream.  After 2nd covid vaccine, itching and rash got worse, spread across face and to back of neck.  Rash "comes and goes", is worse at night and pt. gets short term relief w/the cortisone cream.  Takes Depakote for a seizure condition and has contact allergies to plants and animals; is otherwise healthy.  Has not sought care from her PCP because of cost.  Advised on other OTC measures and if not improved, to see her PCP for eval.  She feels it is not a serious condition but wanted to report it.
On 12/14/2021 63-year-old male patient with a past medical history significant for end-stage renal disease, on hemodialysis, who was admitted on 12/14/2021 with a complaint of weakness and falling. On admission, he had a chest x-ray taken, which showed patchy right lower lobe consolidation. The patient also had a CTA PE protocol done, which currently is pending. The patient was admitted and he was started on Decadron and also continued on rest of his medication. When seen, the patient complained of some dizziness and shortness of breath with mild cough. Denied any fever or any chills. No chest pain. No nausea. No vomiting. No frequency, urgency, or dysuria. No hematochezia, hematemesis.
Patient previously received PCV13 on 10/20/16. She came into the office on 1/27/17. Orders were to administer Tdap and RMA administered PCV13 in error.
Injection site red  4cm in diameter.  Outer edge red, area warm to touch.  Patient states fogginess feeling after injection.
Booster dose was administered to resident prior to the recommended interval, no adverse effect noted, no unusual changes. Resident made aware that booster dose was administered prior to the recommended interval. Resident made aware of possible adverse reaction post vaccine, to inform Nurses if any change of condition occurs and verbalized understanding.  MD aware with order to monitor resident for any possible adverse effect.
At time of both shot, numbing cold tingling of tongue that lasted for days. Shot 1: 5/6/21 developed lymphoedema and lymphadenitis. Shot 2: developed lymphoedema and lymphadenitis within 4 days and continues off and on to present date. I am a Natural Therapeutic Specialist that does not do well with Western Medicine and treated myself and continue to do so. Treatment protocols: Vitamin C (2g) daily, Vitamin D (3g) every 2-3 days, Sage and Oregano baths, lymph drainage massages, and sweat lodges.
Heart pounding, lips swelling (reported).  Pt did not appear to be swollen, pt " felt better" soon after assessment.  Pt refused transport to hospital.
Patient presented to the ED about an hour after receiving COVID vaccination. Per ED notes, " She experienced facial flushing, chest tightness and difficulty breathing.  She has a history of multiple allergies. Her chest feels tight but she has not been hearing herself wheeze she has been coughing quite a bit.  She denies throat tightness.  She feels hot and lightheaded.  She is noticed that her face is red.   Patient was given 50 mg of Benadryl p.o. and 40 mg of prednisone p.o. as well as an albuterol neb.  The albuterol neb gave her significant relief from the chest tightness and I reexamined her lung and she still has no wheezing and she is moving air well.  Sats have been fine the whole time she has been here the facial flushing diminished steadily.  The patient did not want a wait for any more than an hour and a half.  She states she is feeling much better.  I will give her a prescription for prednisone, 5 days and an EpiPen."
On night of vaccine, the chills started. Lasted throughout the night. On the entire day of 1/27/2021- I had chills, my internal temp felt like 89°, even though I had a low grade fever. I had a migraine that felt like my head was going to explode. It caused body aches and neck pain, sinus pressure, dizziness, weakness, nausea, pain in arm at injection site.
Cellulitis, fever, body aches- admitted to Health center  10/9 or 10/10. getting IV antibiotics.
Early in the morning Saturday, the day after the injection, patient became very nauseaus with a bad headache.  She was sick all day on Saturday with nausea and headache.  She could not sleep.  On Sunday, she felt worse and called ambulance.  They came and checked her out.  Said Oxygen level was normal and all her symptoms were normal side effects.  They did not take her to the hospital.  All day Sunday, she continued to be agitated and not able to get comfortable.  She was hot and cold, back and forth.  Her headache was very bad and she felt like she would throw up, but only threw up a little that day.  By Monday, she started not making sense and slurred her words.  We thought this was due to lack of sleep (exhaustion).  Her sugar was high, so we gave her an insulin shot.  She continued to make less and less sense so we called 911 approximately 7 PM on Monday night.  She was hallucinating.  At the hospital, they looked for infection, but could not find any source of infection.  They intubated her and soon after this, her heart stopped breathing.  They performed CPR 3 times, but not successful.  She died at 5 AM Tuesday morning.
Within a few hours, the pain developed in my left arm at the injection shot.  By morning it was extremely painful to move my arm in any direction. Pain feels like it's traveling through my arm to my hand.
Pain developed on the left side of my chest on 2/4/22. The pain is when ever I?m breathing or moving around. It?s especially sharp when laughing, burping, coughing, sneezing. Sitting upright is the most comfortable state to be in. The pain did reach into my shoulder and neck, but has since subsided and now remains in the chest. Treated it with Tylenol and a heating pad to no effect. Went to urgent care on 2/5/22. Vitals were taken, x ray, ecg, and examination were performed. Nothing was reported as abnormal. I was referred to a cardiologist and prescribed naproxen.
Information has been received from a licensed visiting nurse concerning a 9-year-old female with no pertinent medical history or allergies who on 11-SEP-2007 was vaccinated subcutaneous with her second dose of varicella virus vaccine live (Oka/Merck) (Lot # /1094U). There was no concomitant medication. On 13-SEP-2007, the patient developed a red swollen area on her arm the size of a silver dollar after receiving her second vaccination of varicella virus vaccine live (Oka/Merck). The patient's parent sought medical attention via a phone call and no treatment was required. No diagnostic labs were performed. At the time of the report the patient's status was not recovered. A product quality complaint was not involved. Additional information has been requested.
p/receiving vax 12APR95 pt had a noticeable difference in hearing & speech; 2 wk later pt was not hearing clearly only muffled; pt was seen by ENT on 28APR94 given rx Rynatan & Ceclor x 1mo;
Sharp, intense, burning, stabbing pain in Left heel one hour after vaccination on 2/18/21, which I experienced intermittently over 2/19/21, 2/20/21, 2/21/21. On 2/22/21, paresthesia started in my feet, legs, arms, hands, and by 2/23/21 I had it all over my body.  I also have burning/hot sensations in my hands and feet, intermittent buzzing in my right foot, and the sharp, intense pain in my Left heel still comes and goes. As of today, 3/15/21, I am still experiencing the paresthesia, as well as the burning sensations in my feet and hands.
Developed chills and muscle/body aches ~8 hours after receiving the second dose of the COVID-19 vaccine (Moderna).  Later that night developed nausea and decreased appetite.   All of these side effects lasted 36-48 hours, then resolved without treatment.
administered after the expiration time having passed; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered after the expiration time having passed) and NO ADVERSE EVENT (No adverse event) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered after the expiration time having passed) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered after the expiration time having passed) and NO ADVERSE EVENT (No adverse event) outcome was unknown.            Concomitant medications were not reported.  No treatment information was provided by the reporter. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
flat eccymosis at injection site developing into pupuric swelling of left inhected arm speading to left breast and back
extreme muscle soreness, tired- couldn't get out of bed. muscle ache throughout the body, head ache, nausea, still not feeling well
she developed stiffness in all of her joints (knees, hips and shoulder); she developed stiffness in all of her joints (knees, hips and shoulder); The doctors found a little arthritis in the small of her back; They stated she has pseudo gout; she went from being very active to very inactive; This spontaneous case was reported by a patient and describes the occurrence of JOINT STIFFNESS (she developed stiffness in all of her joints (knees, hips and shoulder)), MUSCULOSKELETAL STIFFNESS (she developed stiffness in all of her joints (knees, hips and shoulder)), SPONDYLITIS (The doctors found a little arthritis in the small of her back), CHONDROCALCINOSIS PYROPHOSPHATE (They stated she has pseudo gout) and DECREASED ACTIVITY (she went from being very active to very inactive) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043B21A and 002B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced JOINT STIFFNESS (she developed stiffness in all of her joints (knees, hips and shoulder)), MUSCULOSKELETAL STIFFNESS (she developed stiffness in all of her joints (knees, hips and shoulder)), SPONDYLITIS (The doctors found a little arthritis in the small of her back), CHONDROCALCINOSIS PYROPHOSPHATE (They stated she has pseudo gout) and DECREASED ACTIVITY (she went from being very active to very inactive). The patient was treated with DIHYDROCODEINE PHOSPHATE (HYDROCODEINE) for Pain, at an unspecified dose and frequency. At the time of the report, JOINT STIFFNESS (she developed stiffness in all of her joints (knees, hips and shoulder)), MUSCULOSKELETAL STIFFNESS (she developed stiffness in all of her joints (knees, hips and shoulder)), SPONDYLITIS (The doctors found a little arthritis in the small of her back), CHONDROCALCINOSIS PYROPHOSPHATE (They stated she has pseudo gout) and DECREASED ACTIVITY (she went from being very active to very inactive) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Apr-2021, Blood calcium: high (High) Blood calcium was high.         Patient was treated with unspecified steroids for pain. Concomitant medicine include (Blood pressure medication,Cholesterol Medication,Something for her stomach).   This case was linked to MOD-2021-265643 (Patient Link).
Hard painful lump at site of injection, red, site is hot to the touch. Pt states feeling "tired & run down" since injection.
Approximately 12 hours after vaccination, the patient realized he had a heaviness in his chest and just didn?t feel ?right?.  His Apple Watch told him he was in afib.  So the patient was taken to the ER by his wife where this was confirmed with an EKG.  He was cardioverted back to normal sinus rhythm and he was prescribed Eliquis.  Patient has no prior heart arrhythmias or medical concerns.  Patient is slightly overweight, but has not had any arrhythmia or history of a fib in the past.  Patient was discharged to follow up with his family physician.  All of his blood work was normal.
Difficulty breathing; This is a spontaneous report from a contactable pharmacist. A 54-year-old female patient received her first dose of intramuscular BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 22Dec2020 at 04:15 PM at single dose in left arm for COVID-19 immunisation at the age of 54-year-old. Lot number was ELO140. Medical history was unknown, concomitant medications were unspecified. Patient was not pregnant at the time of vaccination. On 22Dec2020 at 04:30 PM, the patient experienced difficulty in breathing, and she was hospitalized for one day. The patient was treated with EPI for the event. The patient was recovering from the event.; Sender's Comments: Based on the compatible temporal association, the Company considers the event difficulty in breathing is possibly related to vaccination with BNT162B2. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
tenderness, redness and warmth to site of Tdap injection, looked like a mosquito bite
I had my glucose and A1c recently checked and they were both high.  My A1c was 7.3 and for past 4 years it has been under 6.7. I have worked to keep my diabetes under control, my numbers should not be too high.
fever (100.4), chills, body aches, fatigue, nausea 4 days vomiting staring 0415 04/16/21 17 episodes over 19 hr timeframe
This spontaneous report was received from a 64 year old female patient reporting herself with no drug reactions/allergies. The patient's medical history included shingles (8 years ago, in approximately October 2006). In approximately October 2010 (4 years ago), the patient was vaccinated with a single dose of ZOSTAVAX, (dose, frequency, lot number not provided). Concomitant therapies were unspecified by reporter. In approximately September 2014 (about a month ago), the patient developed shingles. No lab diagnostics studies were performed. The patient sought medical attention and was treated with VALTREX, MOTRIN and hydrocodone (dosage, frequencies, manufacturer unknown). The outcome of shingles was reported as not recovered/not resolved. Additional information has been requested.
The evening of receiving the covid vaccine, patient experienced bruising to upper and lateral thigh with mild tenderness.  The lower extremity initially became swollen, then resolved.  Skin of feet began to peel off.  She also experienced mild intermittent chest tightness.
Tremendous headache; Injection site pain; This is a spontaneous report from a contactable consumer, the patient. A 18-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: UNKNOWN) via an unspecified route of administration in the  left arm on 01Apr2021 at 12:00 (at the age of 18-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Patient had drug allergy to amoxicillin. Concomitant medications were reported as not available. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 12:00, the patient experienced tremendous headache and injection site pain. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events of headache and vaccination site pain was recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.